Tudor Investment Corp’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-48,169
| Closed | -$169K | – | 1720 |
|
|
2024
Q3 | $169K | Buy |
48,169
+2,879
| +6% | +$10.1K | ﹤0.01% | 1430 |
|
|
2024
Q2 | $149K | Sell |
45,290
-2,792
| -6% | -$9.16K | ﹤0.01% | 1383 |
|
|
2024
Q1 | $353K | Buy |
+48,082
| New | +$353K | ﹤0.01% | 1189 |
|
|
2023
Q4 | – | Sell |
-50,187
| Closed | -$106K | – | 1629 |
|
|
2023
Q3 | $106K | Sell |
50,187
-4,424
| -8% | -$9.38K | ﹤0.01% | 1382 |
|
|
2023
Q2 | $260K | Buy |
54,611
+2,177
| +4% | +$10.4K | ﹤0.01% | 1308 |
|
|
2023
Q1 | $299K | Sell |
52,434
-350
| -0.7% | -$2K | ﹤0.01% | 1277 |
|
|
2022
Q4 | $533K | Buy |
52,784
+5,785
| +12% | +$58.4K | 0.01% | 1094 |
|
|
2022
Q3 | $1.05M | Buy |
46,999
+10,284
| +28% | +$230K | 0.02% | 785 |
|
|
2022
Q2 | $910K | Buy |
36,715
+21,601
| +143% | +$535K | 0.02% | 856 |
|
|
2022
Q1 | $586K | Sell |
15,114
-18,401
| -55% | -$713K | 0.01% | 1044 |
|
|
2021
Q4 | $1.96M | Buy |
+33,515
| New | +$1.96M | 0.03% | 594 |
|
|
2021
Q2 | – | Sell |
-3,560
| Closed | -$294K | – | 1581 |
|
|
2021
Q1 | $294K | Buy |
+3,560
| New | +$294K | 0.01% | 1302 |
|
|
2020
Q4 | – | Sell |
-42,035
| Closed | -$1.68M | – | 1386 |
|
|
2020
Q3 | $1.68M | Buy |
42,035
+4,325
| +11% | +$173K | 0.07% | 359 |
|
|
2020
Q2 | $1.29M | Buy |
+37,710
| New | +$1.29M | 0.06% | 390 |
|
|
2019
Q4 | – | Sell |
-46,484
| Closed | -$722K | – | 1206 |
|
|
2019
Q3 | $722K | Buy |
+46,484
| New | +$722K | 0.02% | 590 |
|